Showing results (101-110 of 213) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
The pharmacodynamics of aminoglycosidesM K Lacy, D P Nicolau, C H Nightingale, et al.
Connecticut Medicine|August 1, 1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapyP Belliveau, C H Nightingale, R Quintiliani, et al.
Pharmacoeconomics|June 6, 1996
Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patientsD P Nicolau, J W Ross, R Quintiliani, et al.
International Journal of Antimicrobial Agents|August 5, 2000
Population pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimenD Xuan, J F Lu, D P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniaeK B Patel, D P Nicolau, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1988
Effect of protein binding on drug penetration into blister fluidW C Shyu, R Quintiliani, C H Nightingale, et al.
Pharmacotherapy|May 15, 2001
Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumoniaJ J McNabb, C H Nightingale, R Quintiliani, et al.
American Journal of Hospital Pharmacy|May 1, 1988
Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillinL L Briceland, C H Nightingale, R Quintiliani, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methodsM E Klepser, M A Banevicius, R Quintiliani, et al.
Pageof 22